Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: A retrospective observational study

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Kurtz, Pedro ^a   Claassen, Jan ^a   Helbok, Raimund ^a   Schmidt, J M ^a   Fernandez, Luis ^a   Presciutti, Mary ^a   Stuart, R M ^a   Connolly, E S ^a   Lee, Kiwon ^a   Badjatia, Neeraj ^a   Mayer, Stephan A ^a  

^a Milstein Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN; LACTIC ACID; PYRUVIC ACID; GLUCOSE BLOOD LEVEL;

ADULT; AEROBIC METABOLISM; AGE; APACHE; ARTICLE; BRAIN DISEASE; BRAIN METABOLISM; BRAIN PERFUSION; CEREBRAL METABOLIC DISTRESS; CLINICAL ARTICLE; COMATOSE PATIENT; CONTROLLED STUDY; DISTRESS SYNDROME; FEMALE; GLASGOW COMA SCALE; GLUCOSE BRAIN LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOSPITAL DISCHARGE; HUMAN; HYPOGLYCEMIA; INTRACRANIAL PRESSURE; INTRACRANIAL PRESSURE MONITORING; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; MORTALITY; NEUROMONITORING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; SYSTEMIC GLUCOSE VARIABILITY; BLOOD; BRAIN; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; METABOLISM; MICRODIALYSIS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; TRENDS;

ADULT; BLOOD GLUCOSE; BRAIN; ENERGY METABOLISM; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MICRODIALYSIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE;

EID: 84902533732     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13857     Document Type: Article

References (53)

1. Schlenk F, Nagel A, Graetz D, Sarrafzadeh AS. Hyperglycemia and cerebral glucose in aneurysmal subarachnoid hemorrhage. Intensive Care Med 2008, 34:1200-1207. 10.1007/s00134-008-1044-5, 18320167.
2. Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, Parra A, Connolly ES, Mayer SA. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006, 34:617-623. quiz 624.
3. Frontera JA, Fernandez A, Claassen J, Schmidt M, Schumacher HC, Wartenberg K, Temes R, Parra A, Ostapkovich ND, Mayer SA. Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke 2006, 37:199-203. 10.1161/01.STR.0000194960.73883.0f, 16339481.
4. Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, Carter BS, Ogilvy CS, Singhal AB. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2005, 33:1603-1609. quiz 1623, 10.1097/01.CCM.0000168054.60538.2B, 16003069.
5. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005, 64:1348-1353. 10.1212/01.WNL.0000158442.08857.FC, 15851721.
6. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
7. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ, . NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. NICE-SUGAR Study Investigators.
8. Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chioléro R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009, 35:1738-1748. 10.1007/s00134-009-1585-2, 19636533.
9. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008, 300:933-944. 10.1001/jama.300.8.933, 18728267.
10. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, . German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139. 10.1056/NEJMoa070716, 18184958, German Competence Network Sepsis (SepNet).
11. Bederson JB, Connolly ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE, Harbaugh RE, Patel AB, Rosenwasser RH, . American Heart Association Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009, 40:994-1025. 10.1161/STROKEAHA.108.191395, 19164800, American Heart Association.
12. Vespa PM. The implications of cerebral ischemia and metabolic dysfunction for treatment strategies in neurointensive care. Curr Opin Crit Care 2006, 12:119-123. 10.1097/01.ccx.0000216577.57180.bd, 16543786.
13. Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care 2012, 16:R203. 10.1186/cc11812, 3682305, 23082798.
14. Zazulia AR, Videen TO, Powers WJ. Transient focal increase in perihematomal glucose metabolism after acute human intracerebral hemorrhage. Stroke 2009, 40:1638-1643. 10.1161/STROKEAHA.108.536037, 19286594.
15. Schlenk F, Graetz D, Nagel A, Schmidt M, Sarrafzadeh AS. Insulin-related decrease in cerebral glucose despite normoglycemia in aneurysmal subarachnoid hemorrhage. Crit Care 2008, 12:R9. 10.1186/cc6776, 2374587, 18218076.
16. Oddo M, Schmidt JM, Carrera E, Badjatia N, Connolly ES, Presciutti M, Ostapkovich ND, Levine JM, Le Roux P, Mayer SA. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 2008, 36:3233-3238. 10.1097/CCM.0b013e31818f4026, 18936695.
17. Marcoux J, McArthur DA, Miller C, Glenn TC, Villablanca P, Martin NA, Hovda DA, Alger JR, Vespa PM. Persistent metabolic crisis as measured by elevated cerebral microdialysis lactate-pyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury. Crit Care Med 2008, 36:2871-2877. 10.1097/CCM.0b013e318186a4a0, 18766106.
18. Belli A, Sen J, Petzold A, Russo S, Kitchen N, Smith M. Metabolic failure precedes intracranial pressure rises in traumatic brain injury: a microdialysis study. Acta Neurochir (Wien) 2008, 150:461-469. discussion 470, 10.1007/s00701-008-1580-3, 18421408.
19. Vespa PM, O'Phelan K, McArthur D, Miller C, Eliseo M, Hirt D, Glenn T, Hovda DA. Pericontusional brain tissue exhibits persistent elevation of lactate/pyruvate ratio independent of cerebral perfusion pressure. Crit Care Med 2007, 35:1153-1160. 10.1097/01.CCM.0000259466.66310.4F, 17334254.
20. Vespa P, Boonyaputthikul R, McArthur DL, Miller C, Etchepare M, Bergsneider M, Glenn T, Martin N, Hovda D. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med 2006, 34:850-856. 10.1097/01.CCM.0000201875.12245.6F, 16505665.
21. Vespa PM, McArthur D, O'Phelan K, Glenn T, Etchepare M, Kelly D, Bergsneider M, Martin NA, Hovda DA. Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab 2003, 23:865-877.
22. Bergsneider M, Hovda DA, Shalmon E, Kelly DF, Vespa PM, Martin NA, Phelps ME, McArthur DL, Caron MJ, Kraus JF, Becker DP. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg 1997, 86:241-251. 10.3171/jns.1997.86.2.0241, 9010426.
23. Kruyt ND, Biessels GJ, de Haan RJ, Vermeulen M, Rinkel GJ, Coert B, Roos YB. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 2009, 40:e424-e430. 10.1161/STROKEAHA.108.529974, 19390078.
24. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687. 10.1001/jama.295.14.1681, 16609090.
25. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004, 53:955-962. 10.2337/diabetes.53.4.955, 15047610.
26. Brunner R, Adelsmayr G, Herkner H, Madl C, Holzinger U. Glycemic variability and glucose complexity in critically ill patients: a retrospective analysis of continuous glucose monitoring data. Crit Care 2012, 16:R175. 10.1186/cc11657, 3682275, 23031322.
27. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010, 38:838-842. 10.1097/CCM.0b013e3181cc4be9, 20035218.
28. Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009, 13:R91. 10.1186/cc7921, 2717463, 19534781.
29. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008, 36:3008-3013. 10.1097/CCM.0b013e31818b38d2, 18824908.
30. Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JM, May AK. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008, 74:679-685. discussion 685.
31. Ali NA, O'Brien JM, Dungan K, Phillips G, Marsh CB, Lemeshow S, Connors AF, Preiser JC. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008, 36:2316-2321. 10.1097/CCM.0b013e3181810378, 3176449, 18596625.
32. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105:244-252. 10.1097/00000542-200608000-00006, 16871057.
33. Badjatia N, Strongilis E, Prescutti M, Fernandez L, Fernandez A, Buitrago M, Schmidt JM, Mayer SA. Metabolic benefits of surface counter warming during therapeutic temperature modulation. Crit Care Med 2009, 37:1893-1897. 10.1097/CCM.0b013e31819fffd3, 19384208.
34. Badjatia N, Strongilis E, Gordon E, Prescutti M, Fernandez L, Fernandez A, Buitrago M, Schmidt JM, Ostapkovich ND, Mayer SA. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke 2008, 39:3242-3247. 10.1161/STROKEAHA.108.523654, 18927450.
35. Mackenzie IM, Whitehouse T, Nightingale PG. The metrics of glycaemic control in critical care. Intensive Care Med 2011, 37:435-443. 10.1007/s00134-010-2103-2, 21210080.
36. Krinsley JS. Glycemic control in the critically ill - 3 domains and diabetic status means one size does not fit all!. Crit Care 2013, 17:131. 10.1186/cc12584, 3672498, 23594397.
37. Krinsley JS. Glycemic variability in critical illness and the end of Chapter 1. Crit Care Med 2010, 38:1206-1208. 10.1097/CCM.0b013e3181d3aba5, 20335697.
38. Sarrafzadeh A, Haux D, Kuchler I, Lanksch WR, Unterberg AW. Poor-grade aneurysmal subarachnoid hemorrhage: relationship of cerebral metabolism to outcome. J Neurosurg 2004, 100:400-406.
39. Nagel A, Graetz D, Schink T, Frieler K, Sakowitz O, Vajkoczy P, Sarrafzadeh A. Relevance of intracranial hypertension for cerebral metabolism in aneurysmal subarachnoid hemorrhage. Clinical article. J Neurosurg 2009, 111:94-101. 10.3171/2009.1.JNS08587, 19284237.
40. Pan W. Akaike's information criterion in generalized estimating equations. Biometrics 2001, 57:120-125. 10.1111/j.0006-341X.2001.00120.x, 11252586.
41. Pan W. Model selection in estimating equations. Biometrics 2001, 57:529-534. 10.1111/j.0006-341X.2001.00529.x, 11414579.
42. Prentice RL, Zhao LP. Estimating equations for parameters in means and covariances of multivariate discrete and continuous responses. Biometrics 1991, 47:825-839. 10.2307/2532642, 1742441.
43. Sarrafzadeh AS, Nagel A, Czabanka M, Denecke T, Vajkoczy P, Plotkin M. Imaging of hypoxic-ischemic penumbra with (18)F-fluoromisonidazole PET/CT and measurement of related cerebral metabolism in aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2010, 30:36-45. 10.1038/jcbfm.2009.199, 2949093, 19773799.
44. Helbok R, Schmidt JM, Kurtz P, Hanafy KA, Fernandez L, Stuart RM, Presciutti M, Ostapkovich ND, Connolly ES, Lee K, Badjatia N, Mayer SA, Claassen J. Systemic glucose and brain energy metabolism after subarachnoid hemorrhage. Neurocrit Care 2010, 12:317-323. 10.1007/s12028-009-9327-4, 20135362.
45. Vespa PM, Miller C, McArthur D, Eliseo M, Etchepare M, Hirt D, Glenn TC, Martin N, Hovda D. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med 2007, 35:2830-2836. 10.1097/01.CCM.0000295667.66853.BC, 18074483.
46. Vespa P, Bergsneider M, Hattori N, Wu HM, Huang SC, Martin NA, Glenn TC, McArthur DL, Hovda DA. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab 2005, 25:763-774. 10.1038/sj.jcbfm.9600073, 15716852.
47. Sarrafzadeh AS, Haux D, Ludemann L, Amthauer H, Plotkin M, Kuchler I, Unterberg AW. Cerebral ischemia in aneurysmal subarachnoid hemorrhage: a correlative microdialysis-PET study. Stroke 2004, 35:638-643. 10.1161/01.STR.0000116101.66624.F1, 14963287.
48. Hlatky R, Valadka AB, Goodman JC, Contant CF, Robertson CS. Patterns of energy substrates during ischemia measured in the brain by microdialysis. J Neurotrauma 2004, 21:894-906. 10.1089/0897715041526195, 15307902.
49. Barletta JF, Figueroa BE, Deshane R, Blau SA, McAllen KJ. High glucose variability increases cerebral infarction in patients with spontaneous subarachnoid hemorrhage. J Crit Care 2013, 28:798-803. 10.1016/j.jcrc.2012.12.012, 23428707.
50. Krinsley JS. Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol 2009, 3:1292-1301. 10.1177/193229680900300609, 2787029, 20144383.
51. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625. 10.2337/diabetes.54.6.1615, 15919781.
52. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007, 117:910-918. 10.1172/JCI30077, 1838937, 17404617.
53. Suh SW, Hamby AM, Swanson RA. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 2007, 55:1280-1286. 10.1002/glia.20440, 17659530.